Buyer	NHS England — not a council we hold
Supplier	Abbvie Ltd
Supplier	AGB Pharma
Supplier	Aguettant Ltd
Supplier	Alissa Healthcare Research Limited
Supplier	Amarox Limited
Supplier	Aspire Pharma Limited
Supplier	Aventis Pharma ltd t/a Sanofi
Supplier	B. Braun Medical Limited
Supplier	Bowmed Ibisqus Limited
Supplier	Colonis Pharma Ltd
Supplier	Consilient Health Ltd
Supplier	CST Pharma Limited
Supplier	Day Lewis Medical Ltd
Supplier	Desitin Pharma Ltd
Supplier	Dr.Reddy's Laboratories (UK) Limited
Supplier	ennogen healthcare ltd
Supplier	Esteve Pharmaceuticals Ltd
Supplier	Flexipharm Austrading Limited
Supplier	FLYNN PHARMA LTD
Supplier	Fresenius Kabi Limited
Supplier	GENNISIUM PHARMA
Supplier	Gerot Lannach UK Ltd
Supplier	GH Pharma Ltd
Supplier	GlaxoSmithKline UK Limited
Supplier	Glenmark Pharmaceuticals Europe Limited
Supplier	hameln pharma ltd
Supplier	Healthcare Pharma Ltd
Supplier	Ipca Laboratories UK Ltd
Supplier	Janssen-Cilag Ltd
Supplier	Kent Pharma Ltd
Supplier	Lucane Pharma
Supplier	Macleods Pharma UK Limited
Supplier	Martindale Pharma
Supplier	medac Pharma LLP
Supplier	Medreich PLC
Supplier	Mercury Pharmaceuticals Limited
Supplier	Milpharm Ltd/aurobinbdo Primary
Supplier	Morningside Pharmaeuticals
Supplier	Mylan
Supplier	Neuraxpharm UK Ltd
Supplier	Novumgen Limited
Supplier	Organon Pharmaceuticals UK Ltd
Supplier	Otsuka Pharmaceuticals UK Limited
Supplier	Panpharma UK Limited
Supplier	PARI
Supplier	Perennial Pharma Ltd
Supplier	Pfizer Ltd
Supplier	Piramal Critical care Limited
Supplier	Roma Pharmaceuticals Limited
Supplier	Rosemont Pharmaceuticals Limited
Supplier	ROVI Biotech Ltd
Supplier	Sandoz Ltd
Supplier	Seacross Pharmaceuticals Ltd
Supplier	Selective Supplies Ltd.
Supplier	Sobi (Swedish Orphan Biovitrum Ltd)
Supplier	Sun Pharma UK Ltd
Supplier	Teva UK Limited
Supplier	Thornton and Ross Ltd
Supplier	Tillotts Pharma UK Ltd
Supplier	Torbay Pharmaceuticals
Supplier	Venture Healthcare Ltd
Supplier	Wockhardt UK Limited
Supplier	Zentiva Pharma UK Ltd

Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)

Runs	1 Jun 2024 to 31 May 2027
OCID	ocds-b5fd17-92e06515-73f7-4927-9db0-0ae5cae7907f
Notice	Read it on Contracts Finder

Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.